Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs Ozi
CoreAge Rx and Ozi both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxOzi
Ranked #253 · Grade C
Best for: Someone planning around $279 from week five, who has already decided whether a prepaid block is worth it.
Visit OziThe verdict
CoreAge Rx edges out Ozi on the Rx-Readiness Score, 95 to 48 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Ozi is still a genuine option — budget from $279, not $139. Ozi's own line reads "$139 for your first 4 weeks, then $279/mo", while a badge above the same offer calls it "first month 50% off" — so the introductory window is given in weeks in one place and months in another, and it roughly doubles either way. Tirzepatide is the same shape at $189 then $379. Longer commitments genuinely cut the rate, 22% at twelve weeks up to 47% at fifty-two, but they are billed once up front and ship every four weeks, so the discount is bought with flexibility. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Ozi |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 48/100 · C |
| Overall rank | #1 | #253 |
| Semaglutide | $99/mo | $279/mo after the introductory period |
| Tirzepatide | $149/mo | $379/mo after the introductory period |
| Coverage | All 50 states | Not stated on the site |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Ozi
Ranked #253 · Grade C
What we like
- The ongoing price is printed beside the introductory one rather than left to the invoice
- Genuine reductions on longer plans — 22%, 29% and 47%
- Names its clinical layer rather than gesturing at licensed providers
The caveats
- The price roughly doubles after the introductory period — $139 to $279, and $189 to $379 for tirzepatide
- The intro window is four weeks while the ongoing rate is quoted monthly, and a badge calls it a month
- The discounted longer plans are billed once up front, so the saving costs flexibility
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Ozi against other providers on our shortlist.
Or browse the full comparison hub.